---
title: "Doxazosin - Benign prostatic hyperplasia"
sidebar: mydoc_sidebar
permalink: db00590-mesh-d011470-1.html
toc: false 
---


Path ID: `DB00590_MESH_D011470_1`
{% include image.html url="images/db00590-mesh-d011470-1.png" file="db00590-mesh-d011470-1.png" alt="db00590-mesh-d011470-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D017292 | Doxazosin | Drug |
| UniProt:P35348 | Alpha-1A adrenergic receptor | Protein |
| UniProt:P25100 | Alpha-1D adrenergic receptor | Protein |
| GO:0014832 | Urinary bladder smooth muscle contraction | BiologicalProcess |
| HP:0100515 | Pollakisuria | PhenotypicFeature |
| MESH:D011470 | Benign prostatic hyperplasia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Doxazosin | DECREASES ACTIVITY OF | Alpha-1A Adrenergic Receptor |
| Doxazosin | DECREASES ACTIVITY OF | Alpha-1D Adrenergic Receptor |
| Alpha-1A Adrenergic Receptor | POSITIVELY REGULATES | Urinary Bladder Smooth Muscle Contraction |
| Alpha-1D Adrenergic Receptor | POSITIVELY REGULATES | Urinary Bladder Smooth Muscle Contraction |
| Urinary Bladder Smooth Muscle Contraction | POSITIVELY CORRELATED WITH | Pollakisuria |
| Pollakisuria | MANIFESTATION OF | Benign Prostatic Hyperplasia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00590#mechanism-of-action](https://go.drugbank.com/drugs/DB00590#mechanism-of-action){:target="_blank"}